Search studies

ImmUniverse DPP Cohort (AD/UC)

The ImmUniverse Deep Personal Profiling (DPP) cohort is part of the ImmUniverse project and contains Atopic Dermatitis (AD) and Ulcerative Colitis (UC) patients. It involves deep personal profiling of patients through extensive clinical data, multi-modal sampling (blood and tissue), and multi-omics layers to support precision medicine approaches and disease stratification. Longitudinal study, atopic dermatitis, ulcerative colitis, immune-mediated inflammatory diseases, deep personal profiling...

In vivo study

LIH-PREDI-COVID

PREDI-COVID participants` samples and data for COVIRNA

LUCENT-1 (NCT 03518086)

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

LuxPark

The cohort includes people with Parkinson’s disease, atypical parkinsonism, and healthy controls, who have their state of health regularly monitored by specialists over many years. The participants donate samples of body fluids such as blood or urine. They also take part in clinical examinations that analyze movement sequences and test their attention, memory, vision, speech, and sense of smell.

MIBIPA

Non-invasive microbiome-derived multi-omic biomarkers for the early-stage detection and stratification of Parkinson's disease

ND4BB Translocation

OncoTrack

OncoTrack attempts to address the core problems of drug-based cancer therapies: the low response rate of patients to their therapies, as well as its inevitable consequence, the low approval rates of oncology drugs. Only about 10% of cancer drug candidates entering clinical development are granted marketing authorization. Our program is based on two seminal developments: significant progress in our ability to analyze the molecular characteristics of individual tumors and patients (predominantl...